Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
Purpose: Currently, there is no clinical data reported on the therapy of dual biological agents in pediatric-onset inflammatory bowel disease (PIBD) patients in China. The purpose of this study was to evaluate the efficacy and safety of dual biologic therapy or biologics combined with small molecule...
Saved in:
Main Authors: | Cheng Guo, Jin Zhou, Guoli Wang, Jie Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/12/1/75 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01) -
An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01) -
Modern Approaches in the Morphological Diagnosis of Inflammatory Bowel Diseases
by: A. S. Tertychnyy, et al.
Published: (2022-08-01) -
The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
by: Paulina Jakubczyk, et al.
Published: (2025-01-01) -
Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2015-05-01)